|
Volumn 36, Issue 7, 2008, Pages 769-770
|
Myeloprotection following cytotoxic damage: The sooner the better
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLT3 LIGAND;
GRANULOCYTE COLONY STIMULATING FACTOR;
INTERLEUKIN 3;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
STEM CELL FACTOR;
THROMBOPOIETIN;
BONE MARROW APLASIA;
CLONOGENESIS;
CYTOPENIA;
CYTOTOXICITY;
LETTER;
NONHUMAN;
PRIORITY JOURNAL;
RADIATION INJURY;
ANIMALS;
ANTIGENS, CD34;
BONE MARROW CELLS;
CELL DIVISION;
COLONY-FORMING UNITS ASSAY;
CYCLOPHOSPHAMIDE;
DRUG ADMINISTRATION SCHEDULE;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
GRANULOCYTES;
HEMATOPOIETIC STEM CELL MOBILIZATION;
LEUKOCYTE COUNT;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MYELOABLATIVE AGONISTS;
MYELOPOIESIS;
NEUTROPENIA;
PLATELET COUNT;
RECEPTORS, CHEMOKINE;
SPECIFIC PATHOGEN-FREE ORGANISMS;
|
EID: 52449135579
PISSN: 0301472X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.exphem.2008.02.005 Document Type: Letter |
Times cited : (11)
|
References (6)
|